GO
Loading...

Pfizer Inc

More

  • Early Glance: Pharmaceuticals companies Tuesday, 8 Apr 2014 | 10:43 AM ET

    Baxter International Inc. rose$. 24 or. 3 percent, to $72.73. Johnson& Johnson rose$. 04 or percent, to $97.93. Eli Lilly& Co. rose$. 04 or. 1 percent, to $58.66.

  • Final Glance: Pharmaceuticals companies Monday, 7 Apr 2014 | 6:01 PM ET

    Baxter International Inc. fell$. 44 or. 6 percent, to $72.49. Bristol-Myers Squibb Co. rose$. 39 or. 8 percent, to $50.28. Hospira fell$. 37 or. 9 percent, to $43.01.

  • NEW YORK, April 7- Wall Street stocks slumped on Monday, extending a broad retreat in global equities markets from a six-year high touched last week, while U.S. On Wall Street, the biggest decliners were Internet stocks.

  • Alcoa and Pfizer are big market movers Monday, 7 Apr 2014 | 4:37 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:. Pfizer Inc., down 96 cents to $31.20. BlackRock Inc., down $5.03 to $303.89.

  • Internet stocks were among the day's biggest decliners with Amazon.com down 1.6 percent at $317.76 and Yahoo! The Global X Social Media ETF which includes Groupon Inc and LinkedIn fell 2.5 percent.

  • *Internet stocks tumble; Yahoo shares down nearly 5 pct. Internet stocks were the day's biggest decliners with Amazon.com down 2.8 percent at $314.02, Yahoo! The Global X Social Media ETF which includes Facebook and LinkedIn fell 3.4 percent to $17.91.

  • Midday Glance: Pharmaceuticals companies Monday, 7 Apr 2014 | 1:50 PM ET

    Baxter International Inc. rose$. 06 or. 1 percent, to $72.99. Bristol-Myers Squibb Co. rose$. 39 or. 8 percent, to $50.28. Hospira fell$. 55 or 1.3 percent, to $42.83.

  • Most active New York Stock Exchange-traded stocks Monday, 7 Apr 2014 | 1:50 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. AT&T Inc. rose. 5 percent to $35.72 with 17,267,100 shares traded. Advanced Micro Devices Inc. fell 3.4 percent to $3.87 with 15,166,900 shares traded.

  • *Mallinckrodt to buy Questcor for $5.6 bln. *MannKind stumbles; FDA extends drug review date. "We are definitely seeing a little more downside, a continuation from the nasty reversal on Friday," said Ryan Detrick, senior technical strategist at Schaeffer's Investment Research in Cincinnati, Ohio.

  • NEW YORK, April 7- Wall Street stocks sank on Monday, joining a broad retreat in global equities markets from a six-year high touched last week, while U.S. The dollar fell against major currencies as comments from European Central Bank policymakers curbed expectations for more stimulus and boosted the euro against the greenback.

  • *MannKind stumbles; FDA extends drug review date. However, other names such as Facebook Inc, up 1 percent to $57.33 and Gilead Sciences Inc, up 0.8 percent at $72.76, were able to reverse initial declines.

  • *Mallinckrodt to buy Questcor for $5.6 bln. *MannKind stumbles; FDA extends review date for insulin treatment. *Earnings season gets under way this week, with earnings expected from financials JPMorgan Chase& Co and Wells Fargo& Co, as well as retailer Bed, Bath& Beyond.

  • Early movers: QCOR, SYMC, GM, UA & more Monday, 7 Apr 2014 | 7:48 AM ET
    Traders work on the floor of the New York Stock Exchange during early trading on December 16, 2013 in New York City.

    Some of the names on the move ahead of the open.

  • US STOCKS-Futures fall in wake of Friday selloff Monday, 7 Apr 2014 | 7:47 AM ET

    *Mallinckrodt to buy Questcor for $5.6 bln. *MannKind stumbles; FDA extends review date for insulin treatment. *Earnings season gets under way this week, with earnings expected from financials JPMorgan Chase& Co and Wells Fargo& Co, as well as retailer Bed, Bath& Beyond expected.

  • April 6- Pfizer Inc's experimental breast cancer drug in a clinical trial nearly doubled the amount of time patients lived without their disease getting worse, but overall survival was not yet shown to be statistically significant, researchers said. The U.S. Food and Drug Administration has granted "breakthrough" status for palbociclib.

  • Final Glance: Pharmaceuticals companies Friday, 4 Apr 2014 | 6:19 PM ET

    Baxter International Inc. fell$. 46 or. 6 percent, to $72.93. Bristol-Myers Squibb Co. fell$. 98 or 1.9 percent, to $49.89. Hospira fell $1.17 or 2.6 percent, to $43.38.

  • April 4- Halozyme Therapeutics Inc halted a mid-stage trial testing an advanced version of its flagship drug delivery technology in patients with pancreatic cancer, sending its shares tumbling 32 percent.

  • Midday Glance: Pharmaceuticals companies Friday, 4 Apr 2014 | 1:20 PM ET

    Baxter International Inc. rose$. 26 or. 3 percent, to $73.64. Bristol-Myers Squibb Co. fell$. 08 or. 2 percent, to $50.79. Hospira fell $1.15 or 2.6 percent, to $43.40.

  • Most active New York Stock Exchange-traded stocks Friday, 4 Apr 2014 | 1:20 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. AT&T Inc. rose. 3 percent to $35.75 with 15,311,200 shares traded. Advanced Micro Devices Inc. fell 1.1 percent to $3.96 with 14,916,500 shares traded.

  • Early Glance: Pharmaceuticals companies Friday, 4 Apr 2014 | 10:57 AM ET

    Baxter International Inc. rose$. 24 or. 3 percent, to $73.63. Bristol-Myers Squibb Co. rose$. 60 or 1.2 percent, to $51.47. Hospira fell$. 50 or 1.1 percent, to $44.05.

Most Popular Video

Thursday, 17 Apr 2014 | 2:10 AM ET

Bill McDermott, co-CEO of SAP, says cloud computing is "growing faster than everything else" in the company.

Thursday, 17 Apr 2014 | 1:50 AM ET

Edward George, head of soft commodities at Ecobank, says chocolate will become a luxury in Europe as cocoa prices shoot up.

Wednesday, 16 Apr 2014 | 11:31 PM ET

Vera Eve Lim, CFO at Bank Danamon Indonesia, explains why the lender saw a 13 percent drop in first-quarter earnings.